Se. Rier et al., Increased tumor necrosis factor-alpha production by peripheral blood leukocytes from TCDD-exposed rhesus monkeys, TOXICOL SCI, 60(2), 2001, pp. 327-337
Previous work has shown that exposure to 2,3,7,8-tetrachrorodibenzo-p-dioxi
n (TCDD) is associated with a dose-dependent increase in the incidence and
severity of endometriosis in the rhesus monkey, Studies also suggest that i
mmune mechanisms participate in TCDD-mediated toxicity and the pathogenesis
of endometriosis, Thirteen years after TCDD treatment was terminated, we c
haracterized the phenotypic distribution of peripheral blood mononuclear ce
lls (PBMC) from TCDD-exposed and -unexposed rhesus monkeys and determined t
he ability of these cells to produce cytokines and exert cytolytic activity
against NK and T-cell-sensitive cell lines. We also determined whether ele
vated serum levels of TCDD, dioxin-like PHAH congeners, and triglycerides c
orrelated with changes in PBMC phenotype or function. For all animals, TCDD
exposure correlated with increased PBMC tumor necrosis factor-alpha (TNF-a
lpha) secretion in response to stimulation by T-cell mitogen and decreased
cytolytic activity against NK-sensitive target cells. Furthermore, increase
d production of this cytokine by PHA-stimulated leukocytes was associated w
ith elevated serum triglyceride levels. Leukocyte TNF-alpha secretion in re
sponse to viral antigen and PBMC production of interferon gamma (IFN gamma)
, IL-6, and IL-10 following exposure to mitogen or antigen were unaffected
by previous TCDD treatment. Although TCDD exposure was not associated with
changes in PBMC surface antigen expression, elevated serum concentrations o
f TCDD, 1,2,3,6,7,8-hexachlorodibenzofuran and 3,3',4,4',5-pentachlorobiphe
nyl correlated with increased numbers of CD3+/ CD25- and CD3-/CD25f leukocy
tes and enhanced secretion of TNF-alpha by mitogen-stimulated PBMC. These f
indings indicate that TCDD-exposed rhesus monkeys with endometriosis exhibi
t long-term alterations in systemic immunity associated with elevated serum
levels of specific PHAH congeners.